Virtual Medicinal Product (VMP)
-
Linezolid 100mg/5ml oral suspension
Name Details
Current Name
Linezolid 100mg/5ml oral suspension
|
Start Date
29-09-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J01XX08
BNF |
Current BNF
05010700
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05010700
|
Start Date
03-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39718111000001106 |
26-05-2021 |
|
407899006 |
22-08-2005 |
25-05-2021 |
4957411000001100 |
29-09-2003 |
21-08-2005 |
VMP Ingredients
VMP ingredients table
Linezolid |
Based on Ingredient Substance |
|
20 mg |
1 ml |
Name
Linezolid
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Linezolid
-
VMP
(Current) Linezolid 100mg/5ml oral suspension
Virtual Medicinal Product Pack (VMPP) Information
150 ml |
22250 |
Part VIIIA Category C |